HF
CLBTW

HRT Financial’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

HRT Financial’s Portfolio CLBTW Stock Details CLBTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,844
Closed -$7K – 3348
2022
Q3 		$7K Sell
11,844
-12,583
-52% -$10.2K ﹤0.01% 2567
2022
Q2 		$18K Sell
24,427
-10,554
-30% -$9.63K ﹤0.01% 2624
2022
Q1 		$44K Buy
34,981
+438
+1% +$553 ﹤0.01% 2760
2021
Q4 		$60K Sell
34,543
-3,259
-9% -$7.22K ﹤0.01% 2824
2021
Q3 		$81K Buy
+37,802
New +$87K ﹤0.01% 2955

Other funds holding CLBTW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return

HRT Financial's CLBTW Position: Q4 2022 in Review

HRT Financial sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q4 2022, closing a stake of 11,844 shares — an estimated $7K sold.

HRT Financial first reported a position in CLBTW in Q3 2021 and held it in 5 quarters. The position peaked at $81K in Q3 2021. 22 funds tracked by Wall St. Rank hold CLBTW as of Q4 2022.

  • HRT Financial reported no remaining Cellebrite DI Ltd. Warrants position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 11,844 Cellebrite DI Ltd. Warrants shares in Q4 2022, an estimated $7K.
  • HRT Financial first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 5 quarters.
  • HRT Financial's Cellebrite DI Ltd. Warrants position peaked at $81K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.